Metraipolis › archive › dc_472b28853fca
Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers — Europe PMC PMID:41341591
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/41341591
- DOI
- 10.3389/fimmu.2025.1679365
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-08T11:37:58.804Z
- SHA-256 of the archived text
e9f1dc3204c8d07c7fcca9fd39a66ec6bf1908f9f714807f2fb78061013acc33- Stable URL of this page
https://metraipolis.com/documento/dc_472b28853fca
How to cite
Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers — Europe PMC PMID:41341591 — Europe PMC (en), https://europepmc.org/article/MED/41341591 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_472b28853fca (Metraipolis archive dc_472b28853fca, sha256 e9f1dc3204c8d07c7fcca9fd39a66ec6bf1908f9f714807f2fb78061013acc33)
BibTeX
@misc{dc472b28853fca,
title = {Advancing immunotherapy for esophageal cancer: decoding the roles of PD-L1, TME, and tumor-intrinsic biomarkers — Europe PMC PMID:41341591},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/41341591},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_472b28853fca; sha256 e9f1dc3204c8d07c7fcca9fd39a66ec6bf1908f9f714807f2fb78061013acc33},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41341591. Agents can read the archived copy with the MCP tool read_document.